Innoviva (INVA) Accumulated Expenses (2010 - 2026)

Innoviva (INVA) has 17 years of Accumulated Expenses data on file, last reported at $231000.0 in Q1 2026.

• Quarterly Accumulated Expenses fell 72.27% year-over-year to $231000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $231000.0 (down 72.27% YoY) and the FY2025 annual result came in at $29.5 million, down 1.77% from the prior year.
• Accumulated Expenses retreated to $231000.0 in Q1 2026, from $29.5 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $30.0 million in Q4 2024 to a low of $231000.0 in Q3 2025.
• A 5-year average of $6.1 million and a median of $3.4 million in 2023 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Accumulated Expenses jumped 616.09% — and 2025, when it plunged 96.13%.
• Tracing INVA's Accumulated Expenses over 5 years: stood at $4.4 million in 2022, then soared by 61.05% to $7.0 million in 2023, then surged by 327.34% to $30.0 million in 2024, then retreated by 1.77% to $29.5 million in 2025, then plunged by 99.22% to $231000.0 in 2026.
• The last three Accumulated Expenses figures came in at $231000.0 (Q1 2026), $29.5 million (Q4 2025), and $231000.0 (Q3 2025), per Business Quant data.